Supply of Nilotinib pharmaceutical product for Belgian healthcare.
This tender is for the supply of Nilotinib, a pharmaceutical product used in the treatment of certain cancers. The buyer is a Belgian healthcare institution, likely a hospital or public health authority, serving patients requiring this medication. The contract involves the procurement of Nilotinib over a defined period, with specific delivery and quality requirements. Bidders must be authorized pharmaceutical suppliers with relevant certifications for handling and distributing oncology drugs. The scale is implied to be a recurring supply contract, though exact quantities are not specified.